Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Total Non-Current Liabilities (2021 - 2025)

Historic Total Non-Current Liabilities for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $427.7 million.

  • LifeStance Health's Total Non-Current Liabilities fell 566.16% to $427.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $427.7 million, marking a year-over-year decrease of 566.16%. This contributed to the annual value of $443.1 million for FY2024, which is 732.78% down from last year.
  • LifeStance Health's Total Non-Current Liabilities amounted to $427.7 million in Q3 2025, which was down 566.16% from $430.6 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Total Non-Current Liabilities registered a high of $495.2 million during Q2 2023, and its lowest value of $257.2 million during Q2 2021.
  • For the 5-year period, LifeStance Health's Total Non-Current Liabilities averaged around $403.9 million, with its median value being $441.7 million (2024).
  • As far as peak fluctuations go, LifeStance Health's Total Non-Current Liabilities skyrocketed by 8058.67% in 2022, and later crashed by 732.78% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Total Non-Current Liabilities stood at $265.3 million in 2021, then soared by 80.59% to $479.1 million in 2022, then decreased by 0.21% to $478.2 million in 2023, then dropped by 7.33% to $443.1 million in 2024, then dropped by 3.49% to $427.7 million in 2025.
  • Its last three reported values are $427.7 million in Q3 2025, $430.6 million for Q2 2025, and $440.2 million during Q1 2025.